-- Update from Ongoing Phase 1 Clinical Trial of EO-3021 Now Expected Mid-2024 ---- Expanding EO-3021 Clinical Development Program to Include Combination Strategy -- -- Announcing HER3-targeting ADC ...

In the first state indictment related to the state's troubled home elevation grant program, a grand jury on Thursday charged a wheeler-dealer consultant to several shoring contractors with paying off ...

Louisiana officials announced today that they will let applicants for a federal home-elevation grant program collect as much as $100,000 for raising their houses above base flood levels, rather than ...

BOSTON, April 8, 2024 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patients ...